Align Technology, Inc. (ALGN) operates in the healthcare sector, specializing in the design and manufacture of orthodontic products. Its main offerings, Invisalign clear aligners and iTero intraoral scanners, are recognized globally. The stock has shown fluctuating performance, influenced by the company’s robust product portfolio and market expansion.
Align Technology has received a solid "B+" rating, indicating a strong performance across several key financial metrics. Below is a breakdown of the company's fundamental scores.
Category | Score | Score Visualization |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 4 | |
Return on Assets | 5 | |
Debt to Equity | 3 | |
Price to Earnings | 1 | |
Price to Book | 2 |
Over the past period, Align Technology's scores have remained relatively stable, reflecting consistent performance.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-08-28 | 3 | 4 | 4 | 5 | 3 | 1 | 2 |
Previous | 0 | 4 | 4 | 5 | 3 | 1 | 2 |
Analysts have provided varied price targets for ALGN, with a consensus indicating room for positive price movement.
High | Low | Median | Consensus |
---|---|---|---|
$210 | $154 | $182 | $182 |
The majority of analysts recommend buying ALGN, showcasing strong confidence in the stock's potential.
Recommendation | Count | Proportion |
---|---|---|
Strong Buy | 0 | |
Buy | 23 | |
Hold | 8 | |
Sell | 2 | |
Strong Sell | 0 |
Align Technology, Inc. presents a promising investment opportunity, driven by its firm foundation in the orthodontics market and innovative product line. While it faces some market volatility and competition, the company’s technological advantages and global reach enhance growth prospects. Analysts remain optimistic, predominantly rating the stock as a "Buy". Potential investors should weigh both the expected long-term gains against potential short-term market fluctuations.